| Literature DB >> 28090213 |
Bogdan Andor1, Corina Danciu2, Ersilia Alexa3, Istvan Zupko4, Elena Hogea5, Andreea Cioca6, Dorina Coricovac7, Iulia Pinzaru7, Jenel Marian Pătrașcu1, Marius Mioc8, Romeo Teodor Cristina9, Codruta Soica8, Cristina Dehelean7.
Abstract
In recent years, nutraceuticals attracted a great amount of attention in the biomedical research due to their significant contribution as natural agents for prevention of various health issues. Ethanolic extracts from the ungerminated and germinated seeds of Lupinus albus L. and Lupinus angustifolius L. were analyzed for the content in isoflavones (genistein) and cinnamic acid derivatives. Additionally, the extracts were evaluated for antimicrobial, antiproliferative, and anti-inflammatory properties, using in vitro and in vivo tests. Germination proved to be a method of choice in increasing the amount of genistein and cinnamic acid derivatives in both Lupinus albus L. and Lupinus angustifolius L. seeds. Biological evaluation of all vegetal extracts revealed a weak therapeutic potential for both ungerminated and germinated seeds.Entities:
Year: 2016 PMID: 28090213 PMCID: PMC5206418 DOI: 10.1155/2016/7638542
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Cinnamic acid (CA) derivatives determination of the selected extracts expressed as μg/g (two-way ANOVA, Interaction, p = 0.0022, Row Factor, p < 0.0001, and Column Factor, p = 0.0002).
Figure 2HPLC chromatogram for GY determination: (a) extract from ungerminated seed of Lupinus albus; (b) Lupinus angustifolius; (c) germinated seed of Lupinus albus; (d) Lupinus angustifolius. GY: genistein. Data collected at 261 nm (pink line) and 248 nm (black line).
Validation parameters for cinnamic acid (CA) derivatives and free genistein (GY).
| Compounds | Retention time ( | Regression equations | Regression coefficient ( | LOD ( | LOQ ( |
|---|---|---|---|---|---|
| Caffeic acid | 10.4 |
| 0.998† | †0.5 | 0.7 |
| Coumaric acid | 15.4 |
| 0.996 | 0.5 | 0.7 |
| Ferulic acid | 16.1 |
| 0.989 | 0.5 | 0.7 |
| Rosmarinic acid | 17.2 |
| 0.990 | 0.4 | 0.6 |
| Genistein | 14.0 |
| 0.986 | 0.4 | 0.6 |
Figure 3Genistein amount (μg/g) in the analyzed samples (paired Student's t-test, p < 0.029, respectively, p < 0.036).
Antimicrobial activity of the selected extracts expressed as zone of inhibition (mm).
| Reference strain | Chloramphenicol 30 | Fluconazole 25 | A | B | C | D |
|---|---|---|---|---|---|---|
| Zone of inhibition (mm) | ||||||
|
| 30 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 0 | 0 | 0 | 0 | 0 |
|
| 30 | 15 | 0 | 0 | 0 | 0 |
|
| 16 | 0 | 0 | 0 | 0 | 15 |
|
| 30 | 0 | 0 | 0 | 0 | 0 |
Antiproliferative activity of the selected extracts expressed as inhibition % against the mentioned cell lines. Extracts eliciting less than 10% inhibition are considered ineffective and the exact values were not presented for clarity purposes.
| Extract | Final concentration | Inhibition (%) ± SEM | |||
|---|---|---|---|---|---|
| A2780 | MCF7 | MDA-MB-231 | SiHa | ||
| A | 15 | — | — | — | — |
| 50 | — | — | — | — | |
| 150 | — | — | — | 11.42 ± 1.55 | |
|
| |||||
| B | 15 | — | — | — | — |
| 50 | — | — | — | — | |
| 150 | — | 10.54 ± 2.46 | 11.40 ± 1.99 | 18.23 ± 3.23 | |
|
| |||||
| C | 15 | — | — | — | — |
| 50 | — | — | — | 11.65 ± 3.07 | |
| 150 | — | — | — | 27.09 ± 0.85 | |
|
| |||||
| D | 15 | — | — | — | — |
| 50 | — | — | — | 11.26 ± 2.26 | |
| 150 | — | 16.83 ± 3.55 | 10.83 ± 1.10 | 32.53 ± 1.49 | |
Figure 4Ear sections corresponding to groups (a)–(g) were stained with H&E and analyzed for inflammatory response. Magnification 20x; scale bar: 150 μm.
Figure 5Ear edema values for extracts A, B, C, and D using TPA as blank and indomethacin 1% as reference for the anti-inflammatory activity (one-way ANOVA, p = 0.0019, ∗∗).